Related references
Note: Only part of the references are listed.Real-world experience of using ciclosporin-A 0.1% (Ikervis) in the management of ocular surface inflammatory diseases
Rashmi Deshmukh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2022)
Tolerance and Adherence to Cationic 0.1% Cyclosporine in Ocular Graft-versus-Host Disease
Uta Gehlsen et al.
OPHTHALMIC RESEARCH (2021)
Dry eye disease flares: A rapid evidence assessment
Christopher E. Starr et al.
OCULAR SURFACE (2021)
Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra®) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease
John A. Hovanesian et al.
CLINICAL OPHTHALMOLOGY (2021)
If Artificial Tears Aren't Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti -Inflammatory Therapy of Dry Eye Disease
Uwe Pleyer et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2020)
Inflammatory basis for dry eye disease flares
Victor L. Perez et al.
EXPERIMENTAL EYE RESEARCH (2020)
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies
Andrea Leonardi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?
Hans-Georg Eichler et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
Chang Hyun Park et al.
BMC OPHTHALMOLOGY (2019)
Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease
Jennifer Hind et al.
EYE (2019)
Depressive symptoms, resilience, and personality traits in dry eye disease
Tina Kaiser et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Real world big data for clinical research and drug development
Gurparkash Singh et al.
DRUG DISCOVERY TODAY (2018)
Dry Eye
Janine A. Clayton
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study
Marc Labetoulle et al.
CLINICAL THERAPEUTICS (2018)
Should real-world evidence be incorporated into regulatory approvals?
Ernest Spitzer et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting
Christophe Baudouin et al.
ACTA OPHTHALMOLOGICA (2018)
One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease
Christophe Baudouin et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2017)
A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye
Christophe Baudouin et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2017)
Keratitis in Dry Eye Disease and Topical Ciclosporin A
Andrea Leonardi et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2017)
TFOS DEWS II pathophysiology report
Anthony J. Bron et al.
OCULAR SURFACE (2017)
TFOS DEWS II Management and Therapy Report
Lyndon Jones et al.
OCULAR SURFACE (2017)
TFOS DEWS II Definition and Classification Report
Jennifer P. Craig et al.
OCULAR SURFACE (2017)
Health-related quality of life and depression among participants in the Sjogren's International Collaborative Clinical Alliance registry
Annie Chou et al.
RMD OPEN (2017)
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
Christophe Baudouin et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial
Andrea Leonardi et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2016)
Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review
Marguerite McDonald et al.
OCULAR SURFACE (2016)
Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - A randomised comparative study
M. Amrane et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2014)
Assessment of Vision-Related Quality of Life in Dry Eye Patients
Meiyan Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Share Paper
